Novel Comb-Shaped PEG Modification Enhances the Osteoclastic Inhibitory Effect and Bone Delivery of Osteoprotegerin After Intravenous Administration in Ovariectomized Rats

Distribution of KAI-9803, a Novel  -Protein Kinase C Inhibitor, after Intravenous Administration to Rats

(2011) Y. Miyaji et al.   DRUG METABOLISM AND DISPOSITION

PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver

(2010) Motoko Saito-Yabe et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

The pH-Dependent Formation of PEGylated Bovine Lactoferrin by Branched Polyethylene Glycol (PEG)-N-Hydroxysuccinimide (NHS) Active Esters

(2009) Yasuhiro Nojima et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Use of An Intravenous Microdose of 14C-labeled drug and Accelerator Mass Spectrometry to measure Absolute Oral Bioavailability in Dogs; Cross-comparison of Assay Methods by Accelerator Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry

(2009) Yoshihiro Miyaji et al.   Drug Metabolism and Pharmacokinetics

Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate

(2009) Sinéad M. Ryan et al.   JOURNAL OF CONTROLLED RELEASE

Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats

(2009) Y. Miyaji et al.   XENOBIOTICA

Advances in PEGylation of important biotech molecules: delivery aspects

(2008) Sinéad M Ryan et al.   Expert Opinion on Drug Delivery

Enhanced Circulating Half-Life and Antitumor Activity of a Site-Specific Pegylated Interferon-α Protein Therapeutic

(2007) Stacie J. Bell et al.   BIOCONJUGATE CHEMISTRY

Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection

(2007) Yu Seok Youn et al.   JOURNAL OF CONTROLLED RELEASE